XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Revenue:        
Revenue $ 84,151 $ 62,249 $ 155,084 $ 106,370
Cost of sales 28,675 21,184 50,392 33,447
Gross profit 55,476 41,065 104,692 72,923
Operating expenses:        
Research and development 10,596 7,839 20,318 13,640
Sales, general and administrative 72,668 60,659 142,139 101,085
Litigation-related expenses 5,495 1,167 13,027 4,502
Amortization of acquired intangible assets 2,177 1,208 4,407 1,380
Transaction-related expenses   4,771 120 5,783
Restructuring expenses 289 1,173 1,659 1,331
Total operating expenses 91,225 76,817 181,670 127,721
Operating loss (35,749) (35,752) (76,978) (54,798)
Interest and other expense, net:        
Interest expense, net (1,435) (2,394) (2,891) (4,332)
Other income (expense), net 67 (16) 37 (1,905)
Total interest and other expense, net (1,368) (2,410) (2,854) (6,237)
Net loss before taxes (37,117) (38,162) (79,832) (61,035)
Income tax provision 203 43 332 73
Net loss $ (37,320) $ (38,205) $ (80,164) $ (61,108)
Net loss per share, basic $ (0.36) $ (0.39) $ (0.79) $ (0.66)
Net loss per share, diluted $ (0.36) $ (0.39) $ (0.79) $ (0.66)
Weighted average shares outstanding, basic 102,849 98,541 101,422 92,912
Weighted average shares outstanding, diluted 102,849 98,541 101,422 92,912
Products and Services        
Revenue:        
Revenue $ 84,151 $ 61,885 $ 155,069 $ 105,601
International Supply Agreement        
Revenue:        
Revenue   $ 364 $ 15 $ 769